VERSUS: Transforming African Healthcare Intelligence Through Real-World Evidence

VERSUS is an AI-powered real-world evidence and market intelligence platform developed by PBR Life Sciences. It transforms fragmented African healthcare data into standardised, actionable insights for pharmaceutical companies, healthcare providers, regulators, and global health organisations.

By aggregating and harmonising retail pharmacy sell-out data using global clinical and pharmaceutical standards, VERSUS enables stakeholders to understand how medicines are actually used in real-world settings. This supports evidence-based decision-making, improves market access strategies, and strengthens healthcare system planning across underserved and fast-growing markets.

Addressing Gaps in African Healthcare Data
Healthcare decision-making across many African markets is limited by fragmented, inconsistent, and non-standardised data. Pharmacy sell-out information is often manual, incomplete, or inaccessible, making it difficult to accurately assess demand, treatment patterns, and patient access.

Traditional data sources fail to reflect real-world medicine usage, leading to inefficient market access strategies, supply chain challenges, and policy decisions based on assumptions rather than evidence. VERSUS addresses these challenges by creating a trusted, standardised layer of real-world evidence that reflects actual healthcare activity on the ground.

AI-Powered Data Insights and Cloud-Backed Infrastructure
VERSUS leverages advanced analytics and AI-driven models to transform large volumes of raw pharmacy data into structured, decision-ready intelligence. The platform delivers insights across brands, SKUs, therapy areas, regions, and distribution channels, enabling stakeholders to track trends, identify gaps, and respond proactively.

Built on scalable cloud infrastructure, VERSUS ensures secure data processing, high performance, and the ability to expand across multiple markets. This foundation supports continuous data ingestion, advanced analytics, and enterprise-grade reliability for healthcare intelligence at scale.

Key Differentiators

– AI-powered retail pharmacy analytics tailored for African markets
– Standardised real-world evidence aligned to global clinical and pharmaceutical standards
– Multi-country data aggregation and harmonisation
– Brand-level, SKU-level, and therapy-area insights
– Evidence-based market access and launch strategy support
– Scalable, subscription-based data platforms
– Strong local pharmacy data partnerships

VERSUS is designed to move healthcare stakeholders from fragmented information to clear, actionable intelligence.

A Platform Designed for Healthcare Stakeholders

– VERSUS is built to serve a broad healthcare ecosystem, including:
– Pharmaceutical manufacturers and life sciences companies
– Healthcare providers and hospital networks
– Regulators and policymakers
– Global health organisations and development partners

The platform supports commercial strategy, policy design, procurement planning, and health system strengthening initiatives.

Strategic Opportunity with Cloud and AI Technologies
VERSUS aligns with modern cloud and AI ecosystems by enabling scalable analytics, secure data management, and advanced intelligence capabilities. Cloud-based deployment allows rapid expansion into new markets while maintaining performance, data integrity, and regulatory alignment.

This strategic foundation positions VERSUS as a long-term intelligence platform capable of supporting evolving healthcare needs across emerging markets.

Driving Scalable Impact Across Africa and Beyond

VERSUS is currently deployed in Nigeria and Ghana, with extended data partnerships in Kenya. The platform supports:

– Improved pharmaceutical market access and launch execution
– Better-informed supply and distribution planning
– Stronger public health decision-making
– Increased transparency into medicine usage and availability

By standardising real-world evidence at scale, VERSUS enables African healthcare markets to operate with the intelligence depth expected in more mature global systems.

Target Audience

VERSUS is designed for:

– Pharmaceutical companies operating in African and emerging markets
– Enterprise healthcare organisations
– Government health agencies and regulators
– Global health and development organisations
– Research institutions and policy bodies

The platform serves organisations that require accuracy, credibility, and actionable insight in complex healthcare environments.

Building the Future of Healthcare Intelligence
VERSUS is redefining how real-world healthcare data is captured, analysed, and applied across Africa. By transforming fragmented pharmacy data into trusted intelligence, PBR Life Sciences is enabling smarter decisions, improved access to medicines, and stronger health systems.

Through AI-powered analytics and scalable infrastructure, VERSUS is building a future where healthcare strategies in emerging markets are driven by evidence, not assumptions.